Autor: "Wolpin BM" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Emerging Role of Targeted Therapy in Metastatic Pancreatic Adenocarcinoma.
Autorzy:: Huffman BM; Division of Gastrointestinal Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.
Ellis H; Division of Gastrointestinal Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.
Jordan AC; Division of Gastrointestinal Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.
Freed-Pastor WA; Division of Gastrointestinal Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.; Division of Molecular and Cellular Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.
Perez K; Division of Gastrointestinal Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.
Rubinson DA; Division of Gastrointestinal Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.
Sethi N; Division of Gastrointestinal Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.
Singh H; Division of Gastrointestinal Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.
Surana R; Division of Gastrointestinal Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.
Wolpin BM; Division of Gastrointestinal Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.
Aguirre AJ; Division of Gastrointestinal Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.
Cleary JM; Division of Gastrointestinal Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.; Pokaż więcej
Źródło:: Cancers [Cancers (Basel)] 2022 Dec 16; Vol. 14 (24). Date of Electronic Publication: 2022 Dec 16.
Typ publikacji:: Journal Article; Review

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: A multilayered post-GWAS assessment on genetic susceptibility to pancreatic cancer.
Autorzy:: López de Maturana E; Genetic and Molecular Epidemiology Group, Spanish National Cancer Research Center (CNIO), C/Melchor Fernandez Almagro 3, 28029, Madrid, Spain.; CIBERONC, Madrid, Spain.
Rodríguez JA; CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
Alonso L; Genetic and Molecular Epidemiology Group, Spanish National Cancer Research Center (CNIO), C/Melchor Fernandez Almagro 3, 28029, Madrid, Spain.; CIBERONC, Madrid, Spain.
Lao O; CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
Molina-Montes E; Genetic and Molecular Epidemiology Group, Spanish National Cancer Research Center (CNIO), C/Melchor Fernandez Almagro 3, 28029, Madrid, Spain.; CIBERONC, Madrid, Spain.
Martín-Antoniano IA; Genetic and Molecular Epidemiology Group, Spanish National Cancer Research Center (CNIO), C/Melchor Fernandez Almagro 3, 28029, Madrid, Spain.; CIBERONC, Madrid, Spain.
Gómez-Rubio P; Genetic and Molecular Epidemiology Group, Spanish National Cancer Research Center (CNIO), C/Melchor Fernandez Almagro 3, 28029, Madrid, Spain.; CIBERONC, Madrid, Spain.
Lawlor R; ARC-Net Centre for Applied Research on Cancer and Department of Pathology and Diagnostics, University and Hospital Trust of Verona, Verona, Italy.
Carrato A; CIBERONC, Madrid, Spain.; Department of Oncology, Ramón y Cajal University Hospital, IRYCIS, Alcala University, Madrid, Spain.
Hidalgo M; Madrid-Norte-Sanchinarro Hospital, Madrid, Spain.; Weill Cornell Medicine, New York, USA.
Iglesias M; CIBERONC, Madrid, Spain.; Hospital del Mar-Parc de Salut Mar, Barcelona, Spain.
Molero X; Hospital Universitari Vall d'Hebron, Vall d'Hebron Research Institute (VHIR), Barcelona, Spain.; Universitat Autònoma de Barcelona and CIBEREHD, Barcelona, Spain.
Löhr M; Gastrocentrum, Karolinska Institutet and University Hospital, Stockholm, Sweden.
Michalski C; Department of Surgery, Technical University of Munich, Munich, Germany.; Department of Visceral, Vascular and Endocrine Surgery, Martin-Luther-University Halle-WittenberHalle (Saale), Halle, Germany.
Perea J; Department of Surgery, Hospital 12 de Octubre, and Department of Surgery and Health Research Institute, Fundación Jiménez Díaz, Madrid, Spain.
O'Rorke M; Centre for Public Health, Queen's University Belfast, Belfast, UK.; College of Public Health, The University of Iowa, Iowa City, IA, USA.
Barberà VM; Molecular Genetics Laboratory, General University Hospital of Elche, Elche, Spain.
Tardón A; Department of Medicine, Instituto Universitario de Oncología del Principado de Asturias (IUOPA), Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain.; CIBERESP, Madrid, Spain.
Farré A; Department of Gastroenterology and Clinical Biochemistry, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Muñoz-Bellvís L; CIBERONC, Madrid, Spain.; Department of Surgery, Hospital Universitario de Salamanca - IBSAL, Universidad de Salamanca, Salamanca, Spain.
Crnogorac-Jurcevic T; Barts Cancer Institute, Centre for Molecular Oncology, Queen Mary University of London, London, UK.
Domínguez-Muñoz E; Department of Gastroenterology, University Clinical Hospital of Santiago de Compostela, Santiago de Compostela, Spain.
Gress T; Department of Gastroenterology, University Hospital of Giessen and Marburg, Marburg, Germany.
Greenhalf W; Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK.
Sharp L; National Cancer Registry Ireland and HRB Clinical Research Facility, University College Cork, Cork, Ireland.; Newcastle University, Institute of Health & Society, Newcastle, UK.
Arnes L; Centre for Stem Cell Research and Developmental Biology, University of Copenhagen, Copenhagen, Denmark.; Department of Genetics and Development, Columbia University Medical Center, New York, NY, USA.; Department of Systems Biology, Columbia University Medical Center, New York, NY, USA.
Cecchini L; CIBERONC, Madrid, Spain.; Hospital del Mar-Parc de Salut Mar, Barcelona, Spain.
Balsells J; Hospital Universitari Vall d'Hebron, Vall d'Hebron Research Institute (VHIR), Barcelona, Spain.; Universitat Autònoma de Barcelona and CIBEREHD, Barcelona, Spain.
Costello E; Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK.
Ilzarbe L; CIBERONC, Madrid, Spain.; Hospital del Mar-Parc de Salut Mar, Barcelona, Spain.
Kleeff J; Department of Surgery, Technical University of Munich, Munich, Germany.; Department of Visceral, Vascular and Endocrine Surgery, Martin-Luther-University Halle-WittenberHalle (Saale), Halle, Germany.
Kong B; Department of Surgery, Technical University of Munich, Munich, Germany.
Márquez M; Genetic and Molecular Epidemiology Group, Spanish National Cancer Research Center (CNIO), C/Melchor Fernandez Almagro 3, 28029, Madrid, Spain.; CIBERONC, Madrid, Spain.
Mora J; Department of Gastroenterology and Clinical Biochemistry, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
O'Driscoll D; National Cancer Registry Ireland and HRB Clinical Research Facility, University College Cork, Cork, Ireland.
Scarpa A; ARC-Net Centre for Applied Research on Cancer and Department of Pathology and Diagnostics, University and Hospital Trust of Verona, Verona, Italy.
Ye W; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stokholm, Sweden.
Yu J; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stokholm, Sweden.
García-Closas M; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Kogevinas M; CIBERESP, Madrid, Spain.; Institut Municipal d'Investigació Mèdica - Hospital del Mar, Centre de Recerca en Epidemiologia Ambiental (CREAL), Barcelona, Spain.
Rothman N; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Silverman DT; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Albanes D; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Arslan AA; Department of Obstetrics and Gynecology, New York University School of Medicine, New York, NY, USA.; Department of Environmental Medicine, New York University School of Medicine, New York, NY, USA.; Department of Population Health, New York University School of Medicine, New York, NY, USA.
Beane-Freeman L; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Bracci PM; Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA.
Brennan P; International Agency for Research on Cancer (IARC), Lyon, France.
Bueno-de-Mesquita B; Deparment for Determinants of Chronic Diseases (DCD), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Buring J; Division of Preventive Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Canzian F; Genomic Epidemiology Group, German Cancer Research Center (DKFZ, Heidelberg, Germany.
Du M; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Gallinger S; Prosserman Centre for Population Health Research, Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, ON, Canada.
Gaziano JM; Departments of Medicine, Brigham and Women's Hospital, VA Boston and Harvard Medical School, Boston, MA, USA.
Goodman PJ; SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Gunter M; International Agency for Research on Cancer (IARC), Lyon, France.
LeMarchand L; Cancer Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI, USA.
Li D; University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Neale RE; Population Health Department, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
Peters U; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Petersen GM; Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN, USA.
Risch HA; Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT, USA.
Sánchez MJ; Escuela Andaluza de Salud Pública (EASP), Granada, Spain.; Instituto de Investigación Biosanitaria Granada, Granada, Spain.; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.; Universidad de Granada, Granada, Spain.
Shu XO; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.
Thornquist MD; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Visvanathan K; Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN, USA.
Zheng W; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.
Chanock SJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Easton D; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Wolpin BM; Department Medical Oncology, Dana-Farber Cancer Institute, Boston, USA.
Stolzenberg-Solomon RZ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Klein AP; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, USA.
Amundadottir LT; Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Marti-Renom MA; National Centre for Genomic Analysis (CNAG), Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Universitat Pompeu Fabra (UPF), ICREA, Baldiri Reixac 4, 08028, Barcelona, Spain. .
Real FX; CIBERONC, Madrid, Spain.; Epithelial Carcinogenesis Group, Spanish National Cancer Research Center (CNIO), Madrid, Spain.; Departament de Ciències Experimentals i de la Salut, Universitat Pompeu Fabra, Barcelona, Spain.
Malats N; Genetic and Molecular Epidemiology Group, Spanish National Cancer Research Center (CNIO), C/Melchor Fernandez Almagro 3, 28029, Madrid, Spain. .; CIBERONC, Madrid, Spain. .; Pokaż więcej
Corporate Authors:: PanGenEU Investigators
SBC/EPICURO Investigators
Źródło:: Genome medicine [Genome Med] 2021 Feb 01; Vol. 13 (1), pp. 15. Date of Electronic Publication: 2021 Feb 01.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:: Genetic Predisposition to Disease*
Genome-Wide Association Study*
Pancreatic Neoplasms/*genetics
Biomarkers, Tumor/genetics ; Cell Line, Tumor ; Computer Simulation ; Gene Regulatory Networks ; Genome, Human ; Humans ; Linkage Disequilibrium/genetics ; Reproducibility of Results ; Signal Transduction/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Tissue of origin dictates branched-chain amino acid metabolism in mutant Kras-driven cancers.
Autorzy:: Mayers JR; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA. Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA. These authors contributed equally to this work.
Torrence ME; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA. Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA. These authors contributed equally to this work.
Danai LV; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Papagiannakopoulos T; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Davidson SM; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA. Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Bauer MR; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Lau AN; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Ji BW; Center for Computational Biology and Bioinformatics and Department of Systems Biology, Columbia University, New York, NY 10027, USA.
Dixit PD; Center for Computational Biology and Bioinformatics and Department of Systems Biology, Columbia University, New York, NY 10027, USA.
Hosios AM; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA. Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Muir A; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Chin CR; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Freinkman E; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA. Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA. Whitehead Institute for Biomedical Research, Nine Cambridge Center, Cambridge, MA 02142, USA. Broad Institute, Seven Cambridge Center, Cambridge, MA 02142, USA. Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Jacks T; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA. Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA. Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Wolpin BM; Dana-Farber Cancer Institute, Boston, MA 02115, USA.
Vitkup D; Center for Computational Biology and Bioinformatics and Department of Systems Biology, Columbia University, New York, NY 10027, USA.
Vander Heiden MG; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA. Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA. Broad Institute, Seven Cambridge Center, Cambridge, MA 02142, USA. Dana-Farber Cancer Institute, Boston, MA 02115, USA. .; Pokaż więcej
Źródło:: Science (New York, N.Y.) [Science] 2016 Sep 09; Vol. 353 (6304), pp. 1161-5.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
MeSH Terms:: Amino Acids, Branched-Chain/*metabolism
Carcinoma, Non-Small-Cell Lung/*genetics
Carcinoma, Non-Small-Cell Lung/*metabolism
Carcinoma, Pancreatic Ductal/*genetics
Carcinoma, Pancreatic Ductal/*metabolism
Lung Neoplasms/*genetics
Lung Neoplasms/*metabolism
Pancreatic Neoplasms/*genetics
Pancreatic Neoplasms/*metabolism
Proto-Oncogene Proteins p21(ras)/*genetics
Animals ; Gene Expression Regulation, Neoplastic ; Humans ; Male ; Metabolic Networks and Pathways ; Mice ; Mice, Inbred C57BL ; Minor Histocompatibility Antigens/genetics ; Mutation ; Nitrogen/metabolism ; Organ Specificity ; Pregnancy Proteins/genetics ; Transaminases/genetics

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Nurses' Health Study Contributions on the Epidemiology of Less Common Cancers: Endometrial, Ovarian, Pancreatic, and Hematologic.
Autorzy:: Birmann BM; Brenda M. Birmann, Ying Bao, Marta Crous-Bou, Immaculata De Vivo, and Shelley S. Tworoger are with the Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA. Mollie E. Barnard is with the Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston. Kimberly A. Bertrand is with the Slone Epidemiology Center, Boston University, Boston. Brian M. Wolpin is with the Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School.
Barnard ME; Brenda M. Birmann, Ying Bao, Marta Crous-Bou, Immaculata De Vivo, and Shelley S. Tworoger are with the Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA. Mollie E. Barnard is with the Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston. Kimberly A. Bertrand is with the Slone Epidemiology Center, Boston University, Boston. Brian M. Wolpin is with the Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School.
Bertrand KA; Brenda M. Birmann, Ying Bao, Marta Crous-Bou, Immaculata De Vivo, and Shelley S. Tworoger are with the Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA. Mollie E. Barnard is with the Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston. Kimberly A. Bertrand is with the Slone Epidemiology Center, Boston University, Boston. Brian M. Wolpin is with the Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School.
Bao Y; Brenda M. Birmann, Ying Bao, Marta Crous-Bou, Immaculata De Vivo, and Shelley S. Tworoger are with the Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA. Mollie E. Barnard is with the Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston. Kimberly A. Bertrand is with the Slone Epidemiology Center, Boston University, Boston. Brian M. Wolpin is with the Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School.
Crous-Bou M; Brenda M. Birmann, Ying Bao, Marta Crous-Bou, Immaculata De Vivo, and Shelley S. Tworoger are with the Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA. Mollie E. Barnard is with the Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston. Kimberly A. Bertrand is with the Slone Epidemiology Center, Boston University, Boston. Brian M. Wolpin is with the Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School.
Wolpin BM; Brenda M. Birmann, Ying Bao, Marta Crous-Bou, Immaculata De Vivo, and Shelley S. Tworoger are with the Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA. Mollie E. Barnard is with the Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston. Kimberly A. Bertrand is with the Slone Epidemiology Center, Boston University, Boston. Brian M. Wolpin is with the Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School.
De Vivo I; Brenda M. Birmann, Ying Bao, Marta Crous-Bou, Immaculata De Vivo, and Shelley S. Tworoger are with the Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA. Mollie E. Barnard is with the Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston. Kimberly A. Bertrand is with the Slone Epidemiology Center, Boston University, Boston. Brian M. Wolpin is with the Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School.
Tworoger SS; Brenda M. Birmann, Ying Bao, Marta Crous-Bou, Immaculata De Vivo, and Shelley S. Tworoger are with the Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA. Mollie E. Barnard is with the Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston. Kimberly A. Bertrand is with the Slone Epidemiology Center, Boston University, Boston. Brian M. Wolpin is with the Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School.; Pokaż więcej
Źródło:: American journal of public health [Am J Public Health] 2016 Sep; Vol. 106 (9), pp. 1608-15. Date of Electronic Publication: 2016 Jul 26.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Nurses*
Endometrial Neoplasms/*epidemiology
Hematologic Neoplasms/*epidemiology
Ovarian Neoplasms/*epidemiology
Pancreatic Neoplasms/*epidemiology
Adult ; Epidemiologic Studies ; Female ; Humans ; Life Style ; Longitudinal Studies ; Middle Aged ; Prospective Studies ; Risk Factors ; United States/epidemiology ; Women's Health

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer.
Autorzy:: Childs EJ; Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, Maryland, USA.
Mocci E; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
Campa D; 1] Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany. [2] Department of Biology, University of Pisa, Pisa, Italy.
Bracci PM; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA.
Gallinger S; Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada.
Goggins M; Department of Pathology, Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
Li D; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Neale RE; Department of Population Health, QIMR Berghofer Medical Research Institute, Kelvin Grove,Queensland, Australia.
Olson SH; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Scelo G; International Agency for Research on Cancer (IARC), Lyon, France.
Amundadottir LT; Division of Cancer Epidemiology and Genetics, National Cancer Institute, US National Institutes of Health, US Department of Health and Human Services, Bethesda, Maryland, USA.
Bamlet WR; Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.
Bijlsma MF; Laboratory for Experimental Oncology and Radiobiology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
Blackford A; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
Borges M; Department of Pathology, Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
Brennan P; International Agency for Research on Cancer (IARC), Lyon, France.
Brenner H; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany.
Bueno-de-Mesquita HB; 1] Department for Determinants of Chronic Diseases (DCD), National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands. [2] Department of Gastroenterology and Hepatology, University Medical Centre, Utrecht, the Netherlands. [3] Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK. [4] Department of Social and Preventive Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Canzian F; Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Capurso G; Digestive and Liver Disease Unit, 'Sapienza' University of Rome, Rome, Italy.
Cavestro GM; Università Vita Salute San Raffaele and Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ospedale San Raffaele, Milan, Italy.
Chaffee KG; Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.
Chanock SJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, US National Institutes of Health, US Department of Health and Human Services, Bethesda, Maryland, USA.
Cleary SP; 1] Department of Surgery, University Health Network, University of Toronto, Toronto, Ontario, Canada. [2] Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada.
Cotterchio M; 1] Cancer Care Ontario, University of Toronto, Toronto, Ontario, Canada. [2] Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
Foretova L; Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute and Medical Faculty Masaryk University, Brno, Czech Republic.
Fuchs C; 1] Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. [2] Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Funel N; Department of Surgery, Unit of Experimental Surgical Pathology, University Hospital of Pisa, Pisa, Italy.
Gazouli M; Department of Medical Sciences, Laboratory of Biology, School of Medicine, University of Athens, Athens, Greece.
Hassan M; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Herman JM; Department of Radiation Oncology, Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Holcatova I; Institute of Hygiene and Epidemiology, 1st Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.
Holly EA; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA.
Hoover RN; Division of Cancer Epidemiology and Genetics, National Cancer Institute, US National Institutes of Health, US Department of Health and Human Services, Bethesda, Maryland, USA.
Hung RJ; Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada.
Janout V; Department of Preventive Medicine, Faculty of Medicine, Palacky University, Olomouc, Czech Republic.
Key TJ; Cancer Epidemiology Unit, University of Oxford, Oxford, UK.
Kupcinskas J; Department of Gastroenterology, Lithuanian University of Health Sciences, Kaunas, Lithuania.
Kurtz RC; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Landi S; Department of Biology, Section of Genetics, University of Pisa, Pisa, Italy.
Lu L; Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut, USA.
Malecka-Panas E; Department of Digestive Tract Diseases, Medical University of Lodz, Lodz, Poland.
Mambrini A; Department of Oncology, Azienda USL 1 Massa Carrara, Massa Carrara, Italy.
Mohelnikova-Duchonova B; Laboratory of Toxicogenomics, Institute of Public Health, Prague, Czech Republic.
Neoptolemos JP; National Institute for Health Research (NIHR) Pancreas Biomedical Research Unit, Liverpool Clinical Trials Unit and Cancer Research UK Clinical Trials Unit, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, University of Liverpool, Liverpool, UK.
Oberg AL; Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.
Orlow I; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Pasquali C; Department of Surgery, Gastroenterology and Oncology, University of Padua, Padua, Italy.
Pezzilli R; Pancreas Unit, Department of Digestive Diseases, Sant'Orsola-Malpighi Hospital, Bologna, Italy.
Rizzato C; Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Saldia A; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Scarpa A; ARC-NET-Centre for Applied Research on Cancer, University and Hospital Trust of Verona, Verona, Italy.
Stolzenberg-Solomon RZ; Nutritional Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, US National Institutes of Health, Rockville, Maryland, USA.
Strobel O; Department of General Surgery, University Hospital Heidelberg, Heidelberg, Germany.
Tavano F; Division of Gastroenterology and Research Laboratory, IRCCS Scientific Institute and Regional General Hospital 'Casa Sollievo della Sofferenza', San Giovanni Rotondo, Italy.
Vashist YK; Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Vodicka P; Department of Molecular Biology of Cancer, Institute of Experimental Medicine, Academy of Sciences, Prague, Czech Republic.
Wolpin BM; 1] Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. [2] Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Yu H; Epidemiology Program, University of Hawaii Cancer Center, Honolulu, Hawaii, USA.
Petersen GM; Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.
Risch HA; Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut, USA.
Klein AP; 1] Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, Maryland, USA. [2] Department of Pathology, Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.; Pokaż więcej
Źródło:: Nature genetics [Nat Genet] 2015 Aug; Vol. 47 (8), pp. 911-6. Date of Electronic Publication: 2015 Jun 22.
Typ publikacji:: Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
MeSH Terms:: Polymorphism, Single Nucleotide*
Chromosomes, Human, Pair 17/*genetics
Chromosomes, Human, Pair 2/*genetics
Chromosomes, Human, Pair 3/*genetics
Chromosomes, Human, Pair 7/*genetics
Genetic Predisposition to Disease/*genetics
Pancreatic Neoplasms/*genetics
Aged ; Australia ; Europe ; Female ; Gene Frequency ; Genetic Loci/genetics ; Genome-Wide Association Study/methods ; Genotype ; Humans ; Male ; Middle Aged ; North America ; Risk Factors

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development.
Autorzy:: Mayers JR; Koch Institute for Integrative Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA.
Wu C; Department of Etiology and Carcinogenesis, Cancer Institute and Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.; Department of Epidemiology, Harvard School of Public Health, Boston, MA.
Clish CB; Broad Institute of MIT and Harvard University, Cambridge, MA.
Kraft P; Department of Epidemiology, Harvard School of Public Health, Boston, MA.; Department of Biostatistics, Harvard School of Public Health, Boston, MA.
Torrence ME; Koch Institute for Integrative Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA.
Fiske BP; Koch Institute for Integrative Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA.
Yuan C; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.
Bao Y; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.
Townsend MK; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.
Tworoger SS; Department of Epidemiology, Harvard School of Public Health, Boston, MA.; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.
Davidson SM; Koch Institute for Integrative Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA.
Papagiannakopoulos T; Koch Institute for Integrative Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA.
Yang A; Division of Genomic Stability and DNA repair, Department of Radiation Oncology, Dana- Farber Cancer Institute, Boston, MA 02215.
Dayton TL; Koch Institute for Integrative Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA.
Ogino S; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.; Department of Epidemiology, Harvard School of Public Health, Boston, MA.; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.
Stampfer MJ; Department of Epidemiology, Harvard School of Public Health, Boston, MA.; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.; Department of Nutrition, Harvard School of Public Health, Boston, MA.
Giovannucci EL; Department of Epidemiology, Harvard School of Public Health, Boston, MA.; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.; Department of Nutrition, Harvard School of Public Health, Boston, MA.
Qian ZR; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.
Rubinson DA; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.
Ma J; Department of Epidemiology, Harvard School of Public Health, Boston, MA.; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.
Sesso HD; Department of Epidemiology, Harvard School of Public Health, Boston, MA.; Division of Preventive Medicine, Department of Medicine, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA.
Gaziano JM; Division of Preventive Medicine, Department of Medicine, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA.; Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Healthcare System.
Cochrane BB; University of Washington School of Nursing, Seattle, WA.
Liu S; Departments of Epidemiology and Medicine, Brown University, Providence, RI.
Wactawski-Wende J; Department of Social and Preventive Medicine, University at Buffalo, SUNY, Buffalo, NY.
Manson JE; Department of Epidemiology, Harvard School of Public Health, Boston, MA.; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.; Division of Preventive Medicine, Department of Medicine, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA.
Pollak MN; Departments of Oncology and Medicine, McGill University, Montreal, QC, Canada.
Kimmelman AC; Division of Genomic Stability and DNA repair, Department of Radiation Oncology, Dana- Farber Cancer Institute, Boston, MA 02215.
Souza A; Broad Institute of MIT and Harvard University, Cambridge, MA.
Pierce K; Broad Institute of MIT and Harvard University, Cambridge, MA.
Wang TJ; Division of Cardiovascular Medicine, Vanderbilt University, Nashville, TN.
Gerszten RE; Broad Institute of MIT and Harvard University, Cambridge, MA.; Cardiology Division, Massachusetts General Hospital, and Harvard Medical School, Boston, MA.
Fuchs CS; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.
Vander Heiden MG; Koch Institute for Integrative Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA.; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.; Broad Institute of MIT and Harvard University, Cambridge, MA.
Wolpin BM; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.; Department of Medicine, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA.; Pokaż więcej
Źródło:: Nature medicine [Nat Med] 2014 Oct; Vol. 20 (10), pp. 1193-1198. Date of Electronic Publication: 2014 Sep 28.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:: Amino Acids, Branched-Chain/*blood
Carcinoma, Pancreatic Ductal/*blood
Pancreatic Neoplasms/*blood
Adult ; Aged ; Aged, 80 and over ; Animals ; Carcinoma, Pancreatic Ductal/etiology ; Case-Control Studies ; Cohort Studies ; Disease Models, Animal ; Disease Progression ; Female ; Humans ; Male ; Mice ; Mice, 129 Strain ; Mice, Inbred C57BL ; Mice, Knockout ; Middle Aged ; Pancreatic Neoplasms/etiology ; Prospective Studies ; Proto-Oncogene Proteins p21(ras)/genetics ; Risk Factors ; Time Factors

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer.
Autorzy:: Wolpin BM; 1] Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. [2] Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA. [3].
Rizzato C; 1] Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany. [2].
Kraft P; 1] Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA. [2] Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts, USA. [3].
Kooperberg C; 1] Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA. [2].
Petersen GM; 1] Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA. [2].
Wang Z; 1] Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA. [2] Cancer Genomics Research Laboratory, National Cancer Institute, Division of Cancer Epidemiology and Genetics, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.
Arslan AA; 1] Department of Obstetrics and Gynecology, New York University School of Medicine, New York, New York, USA. [2] Department of Environmental Medicine, New York University School of Medicine, New York, New York, USA. [3] New York University Cancer Institute, New York, New York, USA.
Beane-Freeman L; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Bracci PM; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA.
Buring J; 1] Division of Preventive Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA. [2] Division of Aging, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Canzian F; Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Duell EJ; Unit of Nutrition, Environment and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.
Gallinger S; Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.
Giles GG; 1] Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Victoria, Australia. [2] Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia. [3] Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
Goodman GE; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Goodman PJ; Southwest Oncology Group Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Jacobs EJ; Epidemiology Research Program, American Cancer Society, Atlanta, Georgia, USA.
Kamineni A; Group Health Research Institute, Seattle, Washington, USA.
Klein AP; 1] Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. [2] Department of Epidemiology, Bloomberg School of Public Health, Baltimore, Maryland, USA.
Kolonel LN; The Cancer Research Center of Hawaii (retired), Honolulu, Hawaii, USA.
Kulke MH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Li D; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Malats N; Genetic and Molecular Epidemiology Group, CNIO-Spanish National Cancer Research Centre, Madrid, Spain.
Olson SH; Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
Risch HA; Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut, USA.
Sesso HD; 1] Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA. [2] Division of Preventive Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA. [3] Division of Aging, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Visvanathan K; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
White E; 1] Fred Hutchinson Cancer Research Center, Seattle, Washington, USA. [2] Department of Epidemiology, University of Washington, Seattle, Washington, USA.
Zheng W; 1] Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA. [2] Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Abnet CC; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Albanes D; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Andreotti G; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Austin MA; Department of Epidemiology, University of Washington, Seattle, Washington, USA.
Barfield R; Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts, USA.
Basso D; Department of Laboratory Medicine, University Hospital of Padova, Padua, Italy.
Berndt SI; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Boutron-Ruault MC; 1] INSERM, Centre for Research in Epidemiology and Population Health (CESP), Nutrition, Hormones and Women's Health Team, Villejuif, France. [2] University Paris Sud, UMRS 1018, Villejuif, France. [3] Institut Gustave Roussy (IGR), Villejuif, France.
Brotzman M; Westat, Rockville, Maryland, USA.
Büchler MW; Department of General Surgery, University Hospital Heidelberg, Heidelberg, Germany.
Bueno-de-Mesquita HB; 1] National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands. [2] Department of Gastroenterology and Hepatology, University Medical Centre Utrecht, Utrecht, the Netherlands. [3] Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands.
Bugert P; Institute of Transfusion Medicine and Immunology, Medical Faculty Mannheim, Heidelberg University, German Red Cross Blood Service Baden-Württemberg-Hessen, Mannheim, Germany.
Burdette L; 1] Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA. [2] Cancer Genomics Research Laboratory, National Cancer Institute, Division of Cancer Epidemiology and Genetics, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.
Campa D; Division of Cancer Epidemiology, DKFZ, Heidelberg, Germany.
Caporaso NE; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Capurso G; Digestive and Liver Disease Unit, 'Sapienza' University of Rome, Rome, Italy.
Chung C; 1] Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA. [2] Cancer Genomics Research Laboratory, National Cancer Institute, Division of Cancer Epidemiology and Genetics, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.
Cotterchio M; 1] Cancer Care Ontario, University of Toronto, Toronto, Ontario, Canada. [2] Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
Costello E; National Institute for Health Research Liverpool Pancreas Biomedical Research Unit, University of Liverpool, Liverpool, UK.
Elena J; Division of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Funel N; Department of Surgery, Unit of Experimental Surgical Pathology, University Hospital of Pisa, Pisa, Italy.
Gaziano JM; 1] Division of Preventive Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA. [2] Division of Aging, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA. [3] Massachusetts Veteran's Epidemiology, Research and Information Center, Geriatric Research Education and Clinical Center, Veterans Affairs Boston Healthcare System, Boston, Massachusetts, USA.
Giese NA; Department of General Surgery, University Hospital Heidelberg, Heidelberg, Germany.
Giovannucci EL; 1] Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA. [2] Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA. [3] Department of Nutrition, Harvard School of Public Health, Boston, Massachusetts, USA.
Goggins M; 1] Department of Pathology, Sidney Kimmel Cancer Center and Johns Hopkins University, Baltimore, Maryland, USA. [2] Department of Medicine, Sidney Kimmel Cancer Center and Johns Hopkins University, Baltimore, Maryland, USA. [3] Department of Oncology, Sidney Kimmel Cancer Center and Johns Hopkins University, Baltimore, Maryland, USA.
Gorman MJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Gross M; Laboratory of Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota, USA.
Haiman CA; Preventive Medicine, University of Southern California, Los Angeles, California, USA.
Hassan M; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Helzlsouer KJ; Prevention and Research Center, Mercy Medical Center, Baltimore, Maryland, USA.
Henderson BE; Cancer Prevention, University of Southern California, Los Angeles, California, USA.
Holly EA; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA.
Hu N; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Hunter DJ; 1] Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA. [2] Harvard School of Public Health, Boston, Massachusetts, USA. [3] Harvard Medical School, Boston, Massachusetts, USA.
Innocenti F; The University of North Carolina Eshelman School of Pharmacy, Center for Pharmacogenomics and Individualized Therapy, Lineberger Comprehensive Cancer Center, School of Medicine, Chapel Hill, North Carolina, USA.
Jenab M; International Agency for Research on Cancer, Lyon, France.
Kaaks R; Division of Cancer Epidemiology, DKFZ, Heidelberg, Germany.
Key TJ; Cancer Epidemiology Unit, University of Oxford, Oxford, UK.
Khaw KT; School of Clinical Medicine, University of Cambridge, Cambridge, UK.
Klein EA; Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Kogevinas M; 1] Centre de Recerca en Epidemiologia Ambiental (CREAL), CIBER Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain. [2] Hospital del Mar Institute of Medical Research (IMIM), Barcelona, Spain. [3] Department of Nutrition, National School of Public Health, Athens, Greece.
Krogh V; Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Kupcinskas J; Department of Gastroenterology, Lithuanian University of Health Sciences, Kaunas, Lithuania.
Kurtz RC; Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
LaCroix A; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Landi MT; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Landi S; Department of Biology, University of Pisa, Pisa, Italy.
Le Marchand L; Cancer Epidemiology Program, University of Hawaii Cancer Center, Honolulu, Hawaii, USA.
Mambrini A; Oncology Department, ASL1 Massa Carrara, Massa Carrara, Italy.
Mannisto S; Department of Chronic Disease Prevention, National Institute for Health and Welfare, Helsinki, Finland.
Milne RL; 1] Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Victoria, Australia. [2] Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.
Nakamura Y; Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Oberg AL; Alliance Statistics and Data Center, Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.
Owzar K; Alliance Statistics and Data Center, Department of Biostatistics and Bioinformatics, Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina, USA.
Patel AV; Epidemiology Research Program, American Cancer Society, Atlanta, Georgia, USA.
Peeters PH; 1] Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands. [2] Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
Peters U; Department of Epidemiology, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Pezzilli R; Pancreas Unit, Department of Digestive Diseases and Internal Medicine, Sant'Orsola-Malpighi Hospital, Bologna, Italy.
Piepoli A; Department of Gastroenterology, Scientific Institute and Regional General Hospital 'Casa Sollievo della Sofferenza', Opera di Padre Pio da Pietrelcina, San Giovanni Rotondo, Italy.
Porta M; 1] Hospital del Mar Institute of Medical Research (IMIM), Barcelona, Spain. [2] Department of Epidemiology, School of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain. [3] CIBERESP, Madrid, Spain.
Real FX; 1] Epithelial Carcinogenesis Group, CNIO-Spanish National Cancer Research Centre, Madrid, Spain. [2] Departament de Ciències i de la Salut, Universitat Pompeu Fabra, Barcelona, Spain.
Riboli E; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
Rothman N; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Scarpa A; ARC-NET: Centre for Applied Research on Cancer, University and Hospital Trust of Verona, Verona, Italy.
Shu XO; 1] Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA. [2] Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Silverman DT; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Soucek P; Toxicogenomics Unit, Center for Toxicology and Safety, National Institute of Public Health, Prague, Czech Republic.
Sund M; Department of Surgical and Perioperative Sciences, Umeå University, Umeå, Sweden.
Talar-Wojnarowska R; Department of Digestive Tract Diseases, Medical University of Łodz, Łodz, Poland.
Taylor PR; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Theodoropoulos GE; 1st Propaideutic Surgical Department, Hippocration University Hospital, Athens, Greece.
Thornquist M; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Tjønneland A; Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark.
Tobias GS; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Trichopoulos D; 1] Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA. [2] Bureau of Epidemiologic Research, Academy of Athens, Athens, Greece. [3] Hellenic Health Foundation, Athens, Greece.
Vodicka P; Department of Molecular Biology of Cancer, Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Prague, Czech Republic.
Wactawski-Wende J; Department of Social and Preventive Medicine, University at Buffalo, State University of New York, Buffalo, New York, USA.
Wentzensen N; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Wu C; Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA.
Yu H; Cancer Epidemiology Program, University of Hawaii Cancer Center, Honolulu, Hawaii, USA.
Yu K; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Zeleniuch-Jacquotte A; 1] Department of Environmental Medicine, New York University School of Medicine, New York, New York, USA. [2] New York University Cancer Institute, New York, New York, USA.
Hoover R; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Hartge P; 1] Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA. [2].
Fuchs C; 1] Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. [2] Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA. [3].
Chanock SJ; 1] Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA. [2] Cancer Genomics Research Laboratory, National Cancer Institute, Division of Cancer Epidemiology and Genetics, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA. [3].
Stolzenberg-Solomon RS; 1] Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA. [2].
Amundadottir LT; 1] Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA. [2].; Pokaż więcej
Źródło:: Nature genetics [Nat Genet] 2014 Sep; Vol. 46 (9), pp. 994-1000. Date of Electronic Publication: 2014 Aug 03.
Typ publikacji:: Journal Article; Meta-Analysis; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:: Genetic Loci*
Pancreatic Neoplasms/*genetics
Aged ; Case-Control Studies ; Female ; Genetic Predisposition to Disease ; Genome-Wide Association Study/methods ; Genotype ; Humans ; Male ; Middle Aged ; Polymorphism, Single Nucleotide/genetics ; White People/genetics

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Nut consumption and risk of pancreatic cancer in women.
Autorzy:: Bao Y; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, 181 Longwood Avenue, Boston, MA 02115, USA.
Hu FB
Giovannucci EL
Wolpin BM
Stampfer MJ
Willett WC
Fuchs CS; Pokaż więcej
Źródło:: British journal of cancer [Br J Cancer] 2013 Nov 26; Vol. 109 (11), pp. 2911-6. Date of Electronic Publication: 2013 Oct 22.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:: Eating*
Feeding Behavior*
Nuts*
Pancreatic Neoplasms/*epidemiology
Adult ; Aged ; Diet Surveys ; Female ; Humans ; Middle Aged ; Risk Factors ; Surveys and Questionnaires ; United States/epidemiology

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: An absolute risk model to identify individuals at elevated risk for pancreatic cancer in the general population.
Autorzy:: Klein AP; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States of America ; Department of Pathology, Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins School of Medicine, Baltimore, Maryland, United States of America ; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
Lindström S
Mendelsohn JB
Steplowski E
Arslan AA
Bueno-de-Mesquita HB
Fuchs CS
Gallinger S
Gross M
Helzlsouer K
Holly EA
Jacobs EJ
Lacroix A
Li D
Mandelson MT
Olson SH
Petersen GM
Risch HA
Stolzenberg-Solomon RZ
Zheng W
Amundadottir L
Albanes D
Allen NE
Bamlet WR
Boutron-Ruault MC
Buring JE
Bracci PM
Canzian F
Clipp S
Cotterchio M
Duell EJ
Elena J
Gaziano JM
Giovannucci EL
Goggins M
Hallmans G
Hassan M
Hutchinson A
Hunter DJ
Kooperberg C
Kurtz RC
Liu S
Overvad K
Palli D
Patel AV
Rabe KG
Shu XO
Slimani N
Tobias GS
Trichopoulos D
Van Den Eeden SK
Vineis P
Virtamo J
Wactawski-Wende J
Wolpin BM
Yu H
Yu K
Zeleniuch-Jacquotte A
Chanock SJ
Hoover RN
Hartge P
Kraft P; Pokaż więcej
Źródło:: PloS one [PLoS One] 2013 Sep 13; Vol. 8 (9), pp. e72311. Date of Electronic Publication: 2013 Sep 13 (Print Publication: 2013).
Typ publikacji:: Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
MeSH Terms:: Models, Statistical*
Adenocarcinoma/*epidemiology
Diabetes Complications/*epidemiology
Pancreatic Neoplasms/*epidemiology
ABO Blood-Group System ; Adenocarcinoma/complications ; Adenocarcinoma/ethnology ; Adult ; Aged ; Aged, 80 and over ; Case-Control Studies ; Diabetes Complications/ethnology ; Europe/epidemiology ; Female ; Genotype ; Humans ; Male ; Middle Aged ; Odds Ratio ; Pancreatic Neoplasms/complications ; Pancreatic Neoplasms/ethnology ; ROC Curve ; Risk Factors ; Smoking ; United States/epidemiology ; White People

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Detectable clonal mosaicism and its relationship to aging and cancer.
Autorzy:: Jacobs KB; Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI), Rockville, Maryland, USA.
Yeager M
Zhou W
Wacholder S
Wang Z
Rodriguez-Santiago B
Hutchinson A
Deng X
Liu C
Horner MJ
Cullen M
Epstein CG
Burdett L
Dean MC
Chatterjee N
Sampson J
Chung CC
Kovaks J
Gapstur SM
Stevens VL
Teras LT
Gaudet MM
Albanes D
Weinstein SJ
Virtamo J
Taylor PR
Freedman ND
Abnet CC
Goldstein AM
Hu N
Yu K
Yuan JM
Liao L
Ding T
Qiao YL
Gao YT
Koh WP
Xiang YB
Tang ZZ
Fan JH
Aldrich MC
Amos C
Blot WJ
Bock CH
Gillanders EM
Harris CC
Haiman CA
Henderson BE
Kolonel LN
Le Marchand L
McNeill LH
Rybicki BA
Schwartz AG
Signorello LB
Spitz MR
Wiencke JK
Wrensch M
Wu X
Zanetti KA
Ziegler RG
Figueroa JD
Garcia-Closas M
Malats N
Marenne G
Prokunina-Olsson L
Baris D
Schwenn M
Johnson A
Landi MT
Goldin L
Consonni D
Bertazzi PA
Rotunno M
Rajaraman P
Andersson U
Beane Freeman LE
Berg CD
Buring JE
Butler MA
Carreon T
Feychting M
Ahlbom A
Gaziano JM
Giles GG
Hallmans G
Hankinson SE
Hartge P
Henriksson R
Inskip PD
Johansen C
Landgren A
McKean-Cowdin R
Michaud DS
Melin BS
Peters U
Ruder AM
Sesso HD
Severi G
Shu XO
Visvanathan K
White E
Wolk A
Zeleniuch-Jacquotte A
Zheng W
Silverman DT
Kogevinas M
Gonzalez JR
Villa O
Li D
Duell EJ
Risch HA
Olson SH
Kooperberg C
Wolpin BM
Jiao L
Hassan M
Wheeler W
Arslan AA
Bueno-de-Mesquita HB
Fuchs CS
Gallinger S
Gross MD
Holly EA
Klein AP
LaCroix A
Mandelson MT
Petersen G
Boutron-Ruault MC
Bracci PM
Canzian F
Chang K
Cotterchio M
Giovannucci EL
Goggins M
Hoffman Bolton JA
Jenab M
Khaw KT
Krogh V
Kurtz RC
McWilliams RR
Mendelsohn JB
Rabe KG
Riboli E
Tjønneland A
Tobias GS
Trichopoulos D
Elena JW
Yu H
Amundadottir L
Stolzenberg-Solomon RZ
Kraft P
Schumacher F
Stram D
Savage SA
Mirabello L
Andrulis IL
Wunder JS
Patiño García A
Sierrasesúmaga L
Barkauskas DA
Gorlick RG
Purdue M
Chow WH
Moore LE
Schwartz KL
Davis FG
Hsing AW
Berndt SI
Black A
Wentzensen N
Brinton LA
Lissowska J
Peplonska B
McGlynn KA
Cook MB
Graubard BI
Kratz CP
Greene MH
Erickson RL
Hunter DJ
Thomas G
Hoover RN
Real FX
Fraumeni JF Jr
Caporaso NE
Tucker M
Rothman N
Pérez-Jurado LA
Chanock SJ; Pokaż więcej
Źródło:: Nature genetics [Nat Genet] 2012 May 06; Vol. 44 (6), pp. 651-8. Date of Electronic Publication: 2012 May 06.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural
MeSH Terms:: Mosaicism*
Aging/*genetics
Aged ; Chromosome Aberrations ; Female ; Humans ; Male ; Middle Aged ; Neoplasms/genetics ; Risk

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Phase I study of cetuximab, irinotecan, and vandetanib (ZD6474) as therapy for patients with previously treated metastastic colorectal cancer.
Autorzy:: Meyerhardt JA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America. />Ancukiewicz M
Abrams TA
Schrag D
Enzinger PC
Chan JA
Kulke MH
Wolpin BM
Goldstein M
Blaszkowsky L
Zhu AX
Elliott M
Regan E
Jain RK
Duda DG; Pokaż więcej
Źródło:: PloS one [PLoS One] 2012; Vol. 7 (6), pp. e38231. Date of Electronic Publication: 2012 Jun 12.
Typ publikacji:: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:: Antineoplastic Agents/*therapeutic use
Colorectal Neoplasms/*drug therapy
Colorectal Neoplasms/*pathology
ErbB Receptors/*metabolism
Vascular Endothelial Growth Factors/*metabolism
Adult ; Aged ; Antibodies, Monoclonal ; Antibodies, Monoclonal, Humanized ; Antineoplastic Agents/metabolism ; Biomarkers, Tumor/blood ; Camptothecin/analogs & derivatives ; Cetuximab ; Female ; Humans ; Irinotecan ; Kaplan-Meier Estimate ; Male ; Maximum Tolerated Dose ; Middle Aged ; Neoplasm Metastasis ; Piperidines ; Quinazolines ; Tomography, X-Ray Computed ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Plasma 25-hydroxyvitamin D and risk of pancreatic cancer.
Autorzy:: Wolpin BM; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA. />Ng K
Bao Y
Kraft P
Stampfer MJ
Michaud DS
Ma J
Buring JE
Sesso HD
Lee IM
Rifai N
Cochrane BB
Wactawski-Wende J
Chlebowski RT
Willett WC
Manson JE
Giovannucci EL
Fuchs CS; Pokaż więcej
Źródło:: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology [Cancer Epidemiol Biomarkers Prev] 2012 Jan; Vol. 21 (1), pp. 82-91. Date of Electronic Publication: 2011 Nov 15.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:: Pancreatic Neoplasms/*blood
Vitamin D/*analogs & derivatives
Aged ; Case-Control Studies ; Female ; Humans ; Logistic Models ; Male ; Middle Aged ; Prospective Studies ; Risk Factors ; Vitamin D/blood

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Predicted vitamin D status and pancreatic cancer risk in two prospective cohort studies.
Autorzy:: Bao Y; Channing Laboratory, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 181 Longwood Avenue, Boston, MA 02115, USA. />Ng K
Wolpin BM
Michaud DS
Giovannucci E
Fuchs CS; Pokaż więcej
Źródło:: British journal of cancer [Br J Cancer] 2010 Apr 27; Vol. 102 (9), pp. 1422-7. Date of Electronic Publication: 2010 Apr 13.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:: Pancreatic Neoplasms/*epidemiology
Vitamin D/*analogs & derivatives
Adult ; Aged ; Body Mass Index ; Cohort Studies ; Diabetes Mellitus/epidemiology ; Female ; Follow-Up Studies ; Humans ; Life Style ; Male ; Middle Aged ; Motor Activity ; Multivariate Analysis ; Proportional Hazards Models ; Prospective Studies ; Racial Groups ; Risk Factors ; Sex Characteristics ; Smoking/epidemiology ; Vitamin D/blood

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33.
Autorzy:: Petersen GM; Department of Health Sciences Research, College of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Amundadottir L
Fuchs CS
Kraft P
Stolzenberg-Solomon RZ
Jacobs KB
Arslan AA
Bueno-de-Mesquita HB
Gallinger S
Gross M
Helzlsouer K
Holly EA
Jacobs EJ
Klein AP
LaCroix A
Li D
Mandelson MT
Olson SH
Risch HA
Zheng W
Albanes D
Bamlet WR
Berg CD
Boutron-Ruault MC
Buring JE
Bracci PM
Canzian F
Clipp S
Cotterchio M
de Andrade M
Duell EJ
Gaziano JM
Giovannucci EL
Goggins M
Hallmans G
Hankinson SE
Hassan M
Howard B
Hunter DJ
Hutchinson A
Jenab M
Kaaks R
Kooperberg C
Krogh V
Kurtz RC
Lynch SM
McWilliams RR
Mendelsohn JB
Michaud DS
Parikh H
Patel AV
Peeters PH
Rajkovic A
Riboli E
Rodriguez L
Seminara D
Shu XO
Thomas G
Tjønneland A
Tobias GS
Trichopoulos D
Van Den Eeden SK
Virtamo J
Wactawski-Wende J
Wang Z
Wolpin BM
Yu H
Yu K
Zeleniuch-Jacquotte A
Fraumeni JF Jr
Hoover RN
Hartge P
Chanock SJ; Pokaż więcej
Źródło:: Nature genetics [Nat Genet] 2010 Mar; Vol. 42 (3), pp. 224-8. Date of Electronic Publication: 2010 Jan 24.
Typ publikacji:: Journal Article
MeSH Terms:: Chromosomes, Human, Pair 1*
Chromosomes, Human, Pair 13*
Chromosomes, Human, Pair 5*
Genetic Loci*
Carcinoma/*genetics
Pancreatic Neoplasms/*genetics
Case-Control Studies ; Cohort Studies ; Genetic Predisposition to Disease/genetics ; Genome-Wide Association Study ; Humans ; Linkage Disequilibrium ; Polymorphism, Single Nucleotide

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Prospective study of predictors of vitamin D status and survival in patients with colorectal cancer.
Autorzy:: Ng K; Department of Medical Oncology, Dana-Farber Cancer Institute, 44 Binney Street, Boston, MA 02115, USA. Kimmie_ />Wolpin BM
Meyerhardt JA
Wu K
Chan AT
Hollis BW
Giovannucci EL
Stampfer MJ
Willett WC
Fuchs CS; Pokaż więcej
Źródło:: British journal of cancer [Br J Cancer] 2009 Sep 15; Vol. 101 (6), pp. 916-23. Date of Electronic Publication: 2009 Aug 18.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:: Colorectal Neoplasms/*blood
Colorectal Neoplasms/*mortality
Vitamin D/*analogs & derivatives
Adult ; Aged ; Body Mass Index ; Female ; Humans ; Male ; Middle Aged ; Prospective Studies ; Vitamin D/blood